CA2759502C - Purification of immunoconjugates - Google Patents

Purification of immunoconjugates Download PDF

Info

Publication number
CA2759502C
CA2759502C CA2759502A CA2759502A CA2759502C CA 2759502 C CA2759502 C CA 2759502C CA 2759502 A CA2759502 A CA 2759502A CA 2759502 A CA2759502 A CA 2759502A CA 2759502 C CA2759502 C CA 2759502C
Authority
CA
Canada
Prior art keywords
agent
antibody
unconjugated
support
gah
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2759502A
Other languages
English (en)
French (fr)
Other versions
CA2759502A1 (en
Inventor
Mark Snyder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Laboratories Inc
Original Assignee
Bio Rad Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43030882&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2759502(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Rad Laboratories Inc filed Critical Bio Rad Laboratories Inc
Publication of CA2759502A1 publication Critical patent/CA2759502A1/en
Application granted granted Critical
Publication of CA2759502C publication Critical patent/CA2759502C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CA2759502A 2009-04-29 2010-04-28 Purification of immunoconjugates Expired - Fee Related CA2759502C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17389609P 2009-04-29 2009-04-29
US61/173,896 2009-04-29
PCT/US2010/032724 WO2010126979A1 (en) 2009-04-29 2010-04-28 Purification of immunoconjugates

Publications (2)

Publication Number Publication Date
CA2759502A1 CA2759502A1 (en) 2010-11-04
CA2759502C true CA2759502C (en) 2021-02-09

Family

ID=43030882

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2759502A Expired - Fee Related CA2759502C (en) 2009-04-29 2010-04-28 Purification of immunoconjugates

Country Status (5)

Country Link
US (1) US8481694B2 (cg-RX-API-DMAC7.html)
EP (1) EP2424875B1 (cg-RX-API-DMAC7.html)
JP (1) JP5863640B2 (cg-RX-API-DMAC7.html)
CA (1) CA2759502C (cg-RX-API-DMAC7.html)
WO (1) WO2010126979A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5881744B2 (ja) * 2011-02-02 2016-03-09 バイオ−ラッド ラボラトリーズ インコーポレーティッド アルカリ溶液でのアパタイトの表面中和方法
WO2013122834A1 (en) * 2012-02-14 2013-08-22 Bio-Rad Laboratories, Inc. REDUCING pH EXCURSIONS IN ION EXCHANGE CHROMATOGRAPHY
GB201310028D0 (en) * 2013-06-05 2013-07-17 Algeta Asa Pharmaceutical preparation
EP4400507B1 (en) * 2015-09-08 2026-08-05 Waters Technologies Corporation Multidimensional chromatography method for analysis of antibody-drug conjugates
US11661438B2 (en) * 2015-12-21 2023-05-30 Pfizer, Inc. Purification of antibody drug conjugates using a sodium phosphate gradient
US20190100577A1 (en) * 2016-03-24 2019-04-04 The Trustees Of Columbia University In The City Of New York Selectively and fully cleavable fluorescent probes for sequential, itrative immunostaining
EP4574227A3 (en) 2016-09-29 2025-09-03 Bio-Rad Laboratories, Inc. Protein-nanoparticle conjugate purification methods
EP3676281A1 (en) * 2017-08-30 2020-07-08 Ares Trading S.A. Method for purifying proteins

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307016A (en) 1978-03-24 1981-12-22 Takeda Chemical Industries, Ltd. Demethyl maytansinoids
US4256746A (en) 1978-11-14 1981-03-17 Takeda Chemical Industries Dechloromaytansinoids, their pharmaceutical compositions and method of use
JPS55102583A (en) 1979-01-31 1980-08-05 Takeda Chem Ind Ltd 20-acyloxy-20-demethylmaytansinoid compound
JPS55162791A (en) 1979-06-05 1980-12-18 Takeda Chem Ind Ltd Antibiotic c-15003pnd and its preparation
JPS5645483A (en) 1979-09-19 1981-04-25 Takeda Chem Ind Ltd C-15003phm and its preparation
EP0028683A1 (en) 1979-09-21 1981-05-20 Takeda Chemical Industries, Ltd. Antibiotic C-15003 PHO and production thereof
JPS5645485A (en) 1979-09-21 1981-04-25 Takeda Chem Ind Ltd Production of c-15003pnd
WO1982001188A1 (en) 1980-10-08 1982-04-15 Takeda Chemical Industries Ltd 4,5-deoxymaytansinoide compounds and process for preparing same
US4450254A (en) 1980-11-03 1984-05-22 Standard Oil Company Impact improvement of high nitrile resins
US4315929A (en) 1981-01-27 1982-02-16 The United States Of America As Represented By The Secretary Of Agriculture Method of controlling the European corn borer with trewiasine
US4313946A (en) 1981-01-27 1982-02-02 The United States Of America As Represented By The Secretary Of Agriculture Chemotherapeutically active maytansinoids from Trewia nudiflora
US4563304A (en) 1981-02-27 1986-01-07 Pharmacia Fine Chemicals Ab Pyridine compounds modifying proteins, polypeptides or polysaccharides
JPS57192389A (en) 1981-05-20 1982-11-26 Takeda Chem Ind Ltd Novel maytansinoid
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
EP0563475B1 (en) 1992-03-25 2000-05-31 Immunogen Inc Cell binding agent conjugates of derivatives of CC-1065
ATE370961T1 (de) * 1998-05-06 2007-09-15 Genentech Inc Reinigung von antikörpern durch ionenaustauschchromatographie
US6333410B1 (en) 2000-08-18 2001-12-25 Immunogen, Inc. Process for the preparation and purification of thiol-containing maytansinoids
NZ533657A (en) 2002-01-03 2008-01-31 Smithkline Beecham Corp Methods for the preparation of immunoconjugates, in particular maytansinoids conjugated to a monoclonal antibody
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
BRPI0415887B1 (pt) 2003-10-27 2021-01-26 Wyeth métodos para a remoção de agregados de elevado peso molecular utilizando cromatografia de hidroxiapatita
US20060160998A1 (en) * 2005-01-19 2006-07-20 Suk Roelf J Methods for isolation and purification of fluorochrome-antibody conjugates
US7811572B2 (en) 2005-08-24 2010-10-12 Immunogen, Inc. Process for preparing purified drug conjugates
JP5530633B2 (ja) * 2006-01-06 2014-06-25 イー・エム・デイー・ミリポア・コーポレイシヨン アフィニティークロマトグラフィーマトリックスおよびその作成および使用法。
EP2069387A4 (en) * 2006-06-14 2011-02-02 Glaxosmithkline Llc METHODS OF PURIFYING ANTIBODIES USING HYDROXYAPATITE CERAMIC
US7691980B2 (en) * 2007-01-09 2010-04-06 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
US7999085B2 (en) * 2007-01-09 2011-08-16 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers

Also Published As

Publication number Publication date
WO2010126979A1 (en) 2010-11-04
CA2759502A1 (en) 2010-11-04
JP2012525407A (ja) 2012-10-22
US8481694B2 (en) 2013-07-09
EP2424875B1 (en) 2016-01-06
EP2424875A4 (en) 2012-10-31
EP2424875A1 (en) 2012-03-07
JP5863640B2 (ja) 2016-02-16
US20100280228A1 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
US8481694B2 (en) Purification of immunoconjugates
Sadiki et al. Site-specific conjugation of native antibody
Adumeau et al. Site-specifically labeled immunoconjugates for molecular imaging—part 2: peptide tags and unnatural amino acids
US20250171379A1 (en) Radiolabeling of polypeptides
CN108602878B (zh) C端赖氨酸缀合免疫球蛋白
Wen et al. Homogeneous antibody-drug conjugates with dual payloads: potential, methods and considerations
EP3240573B1 (en) Enzymatic conjugation of polypeptides
US5807879A (en) Biotinidase-resistant biotinylated compound and methods of use thereof
JP2025176045A (ja) 大員環キレータ及びその使用方法
Lewis et al. Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions
Tsuchikama et al. Antibody-drug conjugates: recent advances in conjugation and linker chemistries
RU2680404C2 (ru) Способ очистки cys-связанных конъюгатов антитело-лекарственное средство
EP2872894B1 (en) Screening of conjugated antibodies
Kirley et al. Selective disulfide reduction for labeling and enhancement of Fab antibody fragments
Myrhammar et al. Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting
IE67320B1 (en) Cross-linked antibodies and processes for their preparation
EP2988785B1 (en) Method of synthesising adcs using affinity resins
JP2017537975A (ja) 親和性樹脂を用いるADCs合成方法
Horiuchi et al. Hepatic clearance of rat liver aspartate aminotransferase isozymes: evidence for endocytotic uptake via different binding sites on sinusoidal liver cells
Sukumaran et al. Pharmacokinetics/Pharmacodynamics and Disposition of Antibody–Drug Conjugates
CA3082231A1 (en) Antibody glycoconjugates and methods of production and use
WO2025011561A1 (en) Antibody-drug conjugates and production thereof
Shen et al. Site-Specified Conjugating Technology and Application
CN119215193A (zh) 利用环糊精类化合物制备抗体-药物偶联物的方法
HK40032905A (en) Radiolabeling of polypeptides

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150415

MKLA Lapsed

Effective date: 20220428